We are live on ! Find out more
INDP icon

Indaptus Therapeutics
INDP

14 hedge funds and large institutions have $1.08M invested in Indaptus Therapeutics in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

29% more capital invested

Capital invested by funds: $839K → $1.08M (+$241K)

0% less ownership

Funds ownership: 0.25% → 0.25% (-0%)

13% less funds holding

Funds holding: 16 → 14 (-2)

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

Holders
14
Holders Change
-2
Holders Change %
-12.5%
% of All Funds
0.22%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$519
2
Renaissance Technologies
Renaissance Technologies
New York
+$189

Top Sellers

Rank Fund Capital Flow
1
SWP
Stratos Wealth Partners
Ohio
-$38.9K
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$20.9K
3
TRCT
Tower Research Capital (TRC)
New York
-$1.04K
4
Bank of America
Bank of America
North Carolina
-$16
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$463K – – –
IHL
2
Investment House LLC
California
$177K – – –
SAM
3
Strategy Asset Managers
California
$102K – – –
Geode Capital Management
4
Geode Capital Management
Massachusetts
$93.5K – – –
PVI
5
Pine Valley Investments
New Jersey
$89.7K +$74.9K +1,586 New
VCM
6
Vivaldi Capital Management
Illinois
$44.4K – – –
State Street
7
State Street
Massachusetts
$36K – – –
Renaissance Technologies
8
Renaissance Technologies
New York
$36K +$189 +4 +0.6%
Northern Trust
9
Northern Trust
Illinois
$23.9K – – –
TRCT
10
Tower Research Capital (TRC)
New York
$11K -$1.04K -22 -9%
Morgan Stanley
11
Morgan Stanley
New York
$1.53K +$519 +11 +58%
BSB
12
Bangor Savings Bank
Maine
$740 – – –
Wells Fargo
13
Wells Fargo
California
$183 – – –
Osaic Holdings
14
Osaic Holdings
Arizona
$35 – – –
Group One Trading
15
Group One Trading
Illinois
$13 – – –
SWP
16
Stratos Wealth Partners
Ohio
– -$38.9K -958 Closed
Susquehanna International Group
17
Susquehanna International Group
Pennsylvania
– -$20.9K -518 Closed
Bank of America
18
Bank of America
North Carolina
– -$16 – –

INDP Hedge Fund Activity: Q1 2023 in Review

14 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Indaptus Therapeutics (INDP) for Q1 2023, worth a combined $1.08M — up 29% from $839K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of INDP and 1 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 2 added.

The largest buyer was Morgan Stanley, adding an estimated $519. The largest seller was Stratos Wealth Partners, exiting entirely with an estimated $38.9K sold.

  • 14 institutional investors held Indaptus Therapeutics (INDP) as of Q1 2023, down from 16 in Q4 2022.
  • Funds reported $1.08M of Indaptus Therapeutics stock for Q1 2023, up 29% quarter-over-quarter.
  • 1 fund opened new Indaptus Therapeutics positions in Q1 2023 and 3 closed out, a net change of -2 holders.
  • The largest Indaptus Therapeutics buyer in Q1 2023 was Morgan Stanley, an estimated $519 added.
  • The largest Indaptus Therapeutics seller in Q1 2023 was Stratos Wealth Partners, an estimated $38.9K sold.

Based on aggregated 13F filings for Q1 2023.